COPART INC (ACVA) Spending and interest coverage
- R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
- Stock-based compensation / revenue · 12 months: Value 6.63%; Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | (m) | Research and development expense / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Stock-based compensation / revenue · 12 months | 6.63% | Share-based compensation / revenue. Period ending 2026-06-30. $53.11M ÷ $801.34M × 100 ≈ 6.63% |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | (m) | |
| Revenue | 801.34M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | 53.11M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | -56.85M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $801.34M | $53.11M | $-56.85M | (m) | (m) | 6.63% | (m) | (m) |
| 2026-03-31 | (m) | $781.10M | $53.75M | $-58.00M | (m) | (m) | 6.88% | (m) | (m) |
| 2025-12-31 | (m) | $759.61M | $56.86M | $-63.19M | (m) | (m) | 7.49% | (m) | (m) |
| 2025-09-30 | (m) | $735.48M | $63.29M | $-71.14M | (m) | (m) | 8.60% | (m) | (m) |
| 2025-06-30 | (m) | $707.24M | $70.24M | $-64.56M | (m) | (m) | 9.93% | (m) | (m) |
| 2025-03-31 | (m) | $674.16M | $69.75M | $-76.01M | (m) | (m) | 10.35% | (m) | (m) |
| 2024-12-31 | (m) | $637.16M | $68.01M | $-84.11M | (m) | (m) | 10.67% | (m) | (m) |
| 2024-09-30 | (m) | $955.08M | $61.44M | $-85.07M | (m) | (m) | 6.43% | (m) | (m) |
| 2024-06-30 | (m) | $783.75M | $56.03M | $-90.22M | (m) | (m) | 7.15% | (m) | (m) |
| 2024-03-31 | (m) | $623.12M | $52.97M | $-91.37M | $1.78M | (m) | 8.50% | -51.19× | Reported |
| 2023-12-31 | (m) | $481.23M | $49.65M | $-89.68M | $1.56M | (m) | 10.32% | -57.30× | Reported |
| 2023-09-30 | (m) | $101.77M | $49.70M | $-90.20M | $1.50M | (m) | 48.83% | -60.09× | Reported |
| 2023-06-30 | (m) | $207.19M | $46.44M | $-93.00M | $1.30M | (m) | 22.41% | -71.71× | Reported |
| 2023-03-31 | (m) | $322.26M | $43.28M | $-97.95M | $1.08M | (m) | 13.43% | -90.36× | Reported |
| 2022-12-31 | (m) | $421.53M | $39.32M | $-106.21M | $979.00K | (m) | 9.33% | -108.49× | Reported |
| 2022-09-30 | (m) | $423.73M | $32.69M | $-104.61M | $883.00K | (m) | 7.71% | -118.47× | Reported |
| 2022-06-30 | (m) | $410.11M | $32.88M | $-104.17M | $769.00K | (m) | 8.02% | -135.46× | Reported |
| 2022-03-31 | (m) | $392.41M | $27.90M | $-88.76M | $782.00K | (m) | 7.11% | -113.51× | Reported |
| 2021-12-31 | (m) | $358.44M | $23.22M | $-76.81M | $782.00K | (m) | 6.48% | -98.22× | Reported |
| 2021-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | (m) | $208.36M | $5.71M | $-40.65M | $633.00K | (m) | 2.74% | -64.21× | Reported |
| 2020-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | (m) | $106.85M | $998.00K | $-79.28M | $0.00 | (m) | 0.93% | (m) | Reported |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Concentrix Corp (CNXC) | United States | $1.792B | -1.31 |
| Western Union CO (WU) | United States | $1.878B | 6.06 |
| TIC Solutions, Inc. (TIC) | United States | $1.936B | -15.28 |
| Nutex Health Inc. (NUTX) | United States | $1.400B | 6.53 |
| LIQUIDITY SERVICES INC (LQDT) | United States | $1.359B | 44.69 |
| Payoneer Global Inc. (PAYO) | United States | $2.419B | 47.94 |
| QUINSTREET, INC (QNST) | United States | $0.822B | 10.19 |
| MAXIMUS, INC. (MMS) | United States | $2.759B | 7.59 |
| Paysign, Inc. (PAYS) | United States | $0.732B | 29.27 |
| CASS INFORMATION SYSTEMS INC (CASS) | United States | $0.696B | 17.90 |